ctDNA-based Minimal Residual Disease Detection for Resected Pancreatic Adenocarcinoma
NCT05479708
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
150
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Cancer Resectable
Interventions
DEVICE:
ctDNA-based MRD detection
Sponsor
BAIYONG SHEN
Collaborators
[object Object]